当前位置:首页 - 行情中心 - 莲花健康(600186) - 财务分析 - 资产负债表

莲花健康

(600186)

  

流通市值:84.30亿  总市值:84.67亿
流通股本:17.86亿   总股本:17.94亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,367,537,873.81,379,969,037.561,352,872,179.091,379,970,760.49
应收票据及应收账款115,932,616.79113,412,319.64109,041,067.7102,852,835.07
应收账款115,932,616.79113,412,319.64109,041,067.7102,852,835.07
应收款项融资2,733,767.812,913,655.871,988,169.62,011,277.41
预付款项68,166,058.4657,676,135.7882,412,685.6856,125,564.64
其他应收款合计4,156,872.653,643,648.573,410,886.713,915,886.94
存货133,708,854.61107,257,161.8284,402,350.1874,211,106.4
其他流动资产48,976,538.6148,959,888.148,150,790.8750,951,583.29
流动资产平衡项目0000
流动资产合计1,778,969,794.451,751,589,059.061,720,035,341.551,707,796,225.96
非流动资产:
长期股权投资27,486,828.047,631,461.047,848,864.318,032,760.59
投资性房地产1,100,721.31,109,843.311,118,965.321,128,087.33
固定资产236,177,145.91239,154,484.47242,211,002.57246,810,086.29
在建工程33,769,273.8925,286,695.5723,259,140.9620,107,901.94
生产性生物资产375,836.52382,512.21389,187.9395,863.59
使用权资产430,683.55769,715.681,108,747.811,449,769.4
无形资产121,599,904.12122,502,350.48123,404,796.85124,307,243.21
长期待摊费用1,601,263.281,280,197.34--
递延所得税资产260,864,652.49276,470,309.72286,996,940.37293,005,003.47
其他非流动资产--23,767,843.4824,325,042.26
非流动资产平衡项目0000
非流动资产合计683,406,309.1674,587,569.82710,105,489.57719,561,758.08
资产平衡项目0000
资产总计2,462,376,103.552,426,176,628.882,430,140,831.122,427,357,984.04
流动负债:
短期借款-20,000,00020,000,00020,000,000
应付票据及应付账款863,959,897.82880,359,554.6907,572,583.36908,494,235.63
其中:应付票据747,300,000761,900,000741,300,000771,704,000
应付账款116,659,897.82118,459,554.6166,272,583.36136,790,235.63
合同负债73,424,214.5878,216,603.2191,735,762.9183,768,351.89
应付职工薪酬79,464,777.9672,289,731.0268,832,292.5665,297,875.5
应交税费12,354,793.288,738,325.559,088,904.128,750,526.52
其他应付款合计141,977,057.66119,785,653.92114,768,486.75134,388,876.03
其他流动负债8,162,907.898,145,626.189,316,817.129,021,472.72
流动负债平衡项目0000
流动负债合计1,179,343,649.191,187,535,494.481,221,314,846.821,229,721,338.29
非流动负债:
租赁负债610,949.49932,027.491,253,105.491,573,181.9
预计负债18,518,686.8718,518,686.8718,518,686.8718,518,686.87
非流动负债平衡项目0000
非流动负债合计19,129,636.3619,450,714.3619,771,792.3620,091,868.77
负债平衡项目0000
负债合计1,198,473,285.551,206,986,208.841,241,086,639.181,249,813,207.06
所有者权益(或股东权益):
实收资本(或股本)1,793,901,1411,793,901,1411,793,901,1411,793,901,141
资本公积1,083,981,363.211,083,981,363.211,083,981,363.211,083,981,363.21
减:库存股50,007,729.0350,007,729.0350,049,99939,538,486.98
其他综合收益---16,220.2
盈余公积82,922,494.282,922,494.282,922,494.282,922,494.2
未分配利润-1,414,215,302.93-1,458,648,491.93-1,487,820,903.82-1,508,808,057.98
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,496,581,966.451,452,148,777.451,422,934,095.591,412,474,673.65
少数股东权益-232,679,148.45-232,958,357.41-233,879,903.65-234,929,896.67
股东权益平衡项目0000
股东权益合计1,263,902,8181,219,190,420.041,189,054,191.941,177,544,776.98
负债和股东权益合计2,462,376,103.552,426,176,628.882,430,140,831.122,427,357,984.04
公告日期2023-10-162023-08-312023-04-292023-03-31
审计意见(境内)标准无保留意见
TOP↑